Financials

Synchrony Financial: A 21% ROE Card Lender Priced at 8x Earnings

Synchrony is not an operating company you value on revenue and operating margin — it is a monoline consumer-credit lender (private-label and co-branded store cards) whose entire profit-and-loss is a spread business. Money comes in as interest and late fees on $103.8 billion of card loans; money goes out as funding cost, a contractual profit-share paid back to retail partners, and a provision for the loans that will not be repaid. What is left is one of the highest returns on equity in U.S. finance — 21% on equity, 3.0% on assets — yet the stock changes hands at roughly 8x earnings and 1.7x book. The whole investment debate sits in that gap, and the gap is about one thing: how high credit losses run through the cycle.

Source: FY2025 Annual Report (Form 10-K), Summary Highlights [1] and Other Financial and Statistical Data [2].

How a card lender actually earns: the FY2025 profit waterfall

Forget gross margin. Synchrony's income statement runs top-to-bottom as a spread. It earned $22.6 billion of interest income (yield on $100 billion of average loans), paid $4.1 billion of funding cost to leave $18.5 billion of net interest income, then subtracted two lender-specific lines most investors miss: a $4.0 billion retailer share arrangement (RSA) — the contractual slice of each program's profit paid back to partners like Lowe's and Amazon — and a $5.2 billion provision for credit losses. What survives that gauntlet, plus modest fee income, covered $5.1 billion of operating expense and taxes to net $3.55 billion [1].

Source: FY2025 Annual Report (Form 10-K), Summary Highlights — Earnings [1].

Two lines deserve a beginner's footnote because they drive the whole model:

• Retailer Share Arrangements (RSA) are a built-in stabilizer. Synchrony shares program economics with its retail partners, so when a program performs better (lower losses), the partner's cut rises — RSA jumped 17.6% to $4.0 billion in 2025 precisely because charge-offs fell [3]. This is the single most important thing to understand about Synchrony: the RSA absorbs a large share of credit swings in both directions, which is why net earnings are far less volatile than the headline loss rate.
• Provision for credit losses is a forward-looking accrual (CECL) for expected lifetime losses, not actual cash lost. In 2025 the provision fell $1.5 billion year-over-year as Synchrony released reserves; in 2024 it built reserves — the same accounting line, swinging in opposite directions, explains most of the earnings noise between years [1].

The standard year-wise statements

For a spread lender the scannable history is built from net interest margin, returns, efficiency, and per-share compounding — not gross/operating margin. Synchrony has grown net earnings and EPS even as the share count nearly halved.

Source: net income, EPS, equity and shares from reported financials (FY2016–FY2025 10-Ks); NIM, efficiency, ROE/ROA and purchase volume from FY2025 Other Financial and Statistical Data [2] and the corresponding prior-year disclosures.

Two patterns jump out. First, net interest margin has been remarkably stable around 15–16% for a decade — Synchrony lends to a deep-subprime-to-prime mix at high contractual rates, and that spread has survived a zero-rate world and a tightening cycle alike. Second, the share count has fallen from 831 million to 374 million — a 55% reduction — so flat-to-rising net income has produced sharply higher EPS. The dips (2020 COVID, 2023 credit normalization) are credit-driven, not franchise erosion.

Below the headline, the lender-specific three-year income statement shows exactly where the 2023→2025 earnings recovery came from — a collapsing provision more than the top line.

Source: FY2025 Annual Report (Form 10-K), Summary Highlights — Earnings [1].

The crux: the net charge-off cycle

Everything about owning Synchrony reduces to the net charge-off rate — the percentage of loans written off as uncollectible. It is the most volatile input, it drives the provision, and through the RSA it even moves what partners are paid. The chart below is the company's entire equity story in one line.

Source: FY2025 Other Financial and Statistical Data (2023–2025) [2]; FY2022 10-K statistical data (2020–2022) [4]; Q1 2026 figure from the Q1 FY2026 earnings call [5].

Read the arc: stimulus pushed losses to a 2.92% trough in 2021, then normalization carried them to a 6.31% peak in 2024 before improving to 5.65% in 2025 and 5.42% in Q1 2026 [5]. The improvement is not luck — it reflects deliberate "product, pricing and policy changes" (PPPCs) and tighter underwriting that shifted the book toward higher credit quality. Management now expects net charge-offs below 5.5% for full-year 2026, with losses peaking seasonally in Q2 [6], and frames its long-term target range at 5.5–6.0% [3].

Asset-quality leading indicators confirm the trend rather than contradict it: over-30-day delinquencies fell to 4.49% (from 4.70%) and the allowance coverage ratio eased to 10.06% of loans — still a thick $10.4 billion cushion, more than 1.7x a full year of charge-offs [1].

Late fees alone contributed roughly $2.3 billion of the interest-income line in 2025 [7], and the CFPB final rule on those fees was vacated in April 2025 [8].

Earnings quality: does it convert to distributable capital?

For a deposit-funded lender, "free cash flow" is the wrong lens — operating cash flow (~$9.9 billion in 2025) is dominated by loan and funding flows, and there is essentially no growth capex. The right test of earnings quality is whether reported profit converts into capital the company can actually return, and whether reserves are honest. On both counts Synchrony scores well: it returned roughly 95% of net earnings in 2025 — $2.9 billion of buybacks plus $427 million of dividends ($1.15/share) — without eroding its capital ratios [1].

Source: net earnings and capital returned from reported cash-flow statements (FY2021–FY2025); FY2025 amounts confirmed in the 10-K Summary Highlights [1].

The one earnings-quality caveat is structural to all CECL lenders: a chunk of 2025's profit came from a reserve release rather than spread, so a reader should mentally separate "core spread earnings" from "reserve tailwind." That tailwind reverses if credit turns — which is exactly why the charge-off rate, not EPS, is the metric to track. Management itself flags that further reserve release is possible but not something to underwrite today.

Balance sheet and funding: a genuine fortress

This is where Synchrony has quietly transformed since its 2014 spin-off from GE. It is now deposit-funded: $81.1 billion of deposits represent 84% of total funding, of which $75.2 billion are sticky direct retail deposits and only $5.9 billion are brokered [9]. Unsecured wholesale notes are just $6.8 billion of a $119 billion balance sheet, so refinancing risk is minimal and the funding base reprices down as rates fall — cost of funds already dropped 44 bps to 4.28% in 2025 [3].

Source: FY2025 Annual Report (Form 10-K), Consolidated Statement of Financial Position [10].

Capital and liquidity are equally comfortable. The CET1 ratio is 12.6% (Common Equity Tier 1 — the core regulatory capital buffer relative to risk-weighted assets; well above the ~7% minimum), the total risk-based capital ratio is 15.8%, and liquid assets of $16.6 billion equal 13.9% of total assets [11] [12]. Crucially, management estimates its earnings power generates roughly 350 bps of CET1 per year — far more than it needs to grow — which is what funds the relentless buyback [13].

Capital allocation: a per-share compounding machine

Synchrony's defining financial trait is the conversion of a stable franchise into per-share value through buybacks. With the stock below 1.7x book and a 21% ROE, repurchasing shares is highly accretive, and management has leaned in hard.

Source: diluted shares from reported income statements (FY2016–FY2025 10-Ks). Over the same span diluted EPS rose from $2.71 to $9.28.

The buyback is funded, not borrowed: book value per share still rose to $44.80 at year-end 2025 from $39.58 a year earlier (+13%), because retained earnings grew while the denominator shrank, and Q1 2026 added another 8% growth in tangible book value per share [10] [5]. With $1.2 billion of authorization left at year-end, the Board then approved a new $6.5 billion repurchase program in Q1 2026 — over a fifth of the entire market cap — signaling years of buyback runway [12] [6].

This is the rare case where management compounds per-share value rather than merely growing assets: total assets have grown only ~4% a year, but EPS has compounded far faster because the share count is melting.

Valuation: cheap relative to its own returns

Nothing is cheap or expensive in isolation. The right frame for a balance-sheet business is price-to-book against ROE (a 21% ROE business should command a premium to book) and P/E against the durability of those earnings. Synchrony trades at ~8.1x trailing EPS and ~1.68x book at $75.26 — and consensus 2026 EPS of ~$9.28 (within management's $9.10–$9.50 guide) leaves the forward multiple in single digits even before the new buyback shrinks the share count further.

Source: market caps and reported FY2025 net income/equity for each issuer; multiples derived from those figures and current prices. Peer set per Synchrony's named competitors.

The peer table needs a caution: most of these "peers" are not clean comparables. Capital One's 2.2% ROE and 51x P/E are distorted by the one-time CECL "double provision" on the Discover acquisition, not run-rate economics; Citigroup is a diversified global bank; American Express earns a deserved 6.9x book premium for its affluent, spend-centric network; and PayPal/Affirm are payments/BNPL businesses, not balance-sheet card lenders. The genuinely comparable pure-play is Bread Financial (BFH) — also a private-label card issuer — and Synchrony out-earns it (21% vs 16% ROE) at a similar P/E, while carrying far more scale and a stronger deposit base.

Source: ROE from reported FY2025 financials; P/Book derived from current market caps and reported equity.

Plot P/B against ROE and Synchrony looks under-rewarded: it earns an AXP-like return on equity (21%) but trades near the book multiple of low-return banks. The market is applying a "monoline subprime card lender" discount — pricing the risk that losses re-accelerate or that regulation (late fees, Basel III endgame, partner concentration) bites. Consensus is more constructive than the multiple implies: the average analyst price target of ~$89 sits ~19% above the current $75.26, consistent with the view that credit is normalizing favorably and capital return is accelerating. The stock is cheap on quality, fairly-to-cheaply priced on through-cycle risk — which is the correct way to hold it.

Note: standard third-party quality scores (Quality Score, Fair Value, Altman Z, Piotroski F) were not available in this run's dataset, so the quality and value judgments here rest on the primary filings and reported financials rather than a packaged screen.

What the financials confirm — and the one metric to watch

The numbers confirm a high-quality, high-return franchise with a fortress deposit balance sheet and best-in-class capital return — and they confirm that its earnings volatility is real and credit-driven, not a quality defect. They contradict any "cheap because the franchise is broken" thesis: NIM is stable at 15%, the funding base has de-risked, the late-fee overhang is gone, and book value compounds through an aggressive but self-funded buyback. The valuation discount is about cyclicality and regulation, not deterioration.

The risk to respect is concentration and cycle: a handful of partner programs drive the book (though the five largest average 14-year relationships, and Lowe's spans 46 years [3]), and a consumer recession would push charge-offs back toward — or past — the top of the 5.5–6.0% range, forcing a provision build that the RSA only partly offsets.

The first financial metric to watch is the net charge-off rate. It is the master variable: it sets the provision (the largest swing line in the income statement), it moves the RSA payment to partners, and it is what the market's discount is really about. Management guides below 5.5% for 2026 (Q1 already at 5.42%); holding under ~5.75% keeps the reserve-release tailwind and the 21% ROE intact, while any drift back toward or above 6% would compress earnings and validate the market's caution. Watch it quarter by quarter, alongside the 30-plus-day delinquency rate as its early warning.